Bavarian Nordic's vaccine against smallpox and monkeypox appears to be working

Data from the US suggests that Bavarian Nordic’s vaccine against monkeypox does, in fact, prevent infections.
Photo: Patrick T. Fallon/AFP / AFP
Photo: Patrick T. Fallon/AFP / AFP
by marketwire, translated by daniel pedersen

Bavarian Nordic’s vaccine for smallpox and monkeypox, known regionally as either Jynneos, Imvanex, or Imvamune, has demonstrated an effect on the prevention of monkeypox, which comes after a study in the Netherlands questioned the vaccine’s efficacy in the beginning of September, Danish business daily Børsen reports.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading